Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.6808
-0.0032 (-0.47%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Envoy Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 52 | 51 | 19 | 18 | 31 | 28 | 30 | 61 | 44 | 73 | 35 | 137 | 104 | 102 | 101 | 99 | 99 | 99 | 517 | - | |
Market Cap Growth (YoY) | 63.88% | 84.43% | -37.28% | -69.66% | -30.38% | -61.98% | -14.06% | -55.64% | -57.65% | -28.33% | -65.01% | 38.06% | 4.48% | 2.86% | -80.40% | - | - | - | - | - |
Enterprise Value | 27.98 | 27.16 | 16.7 | 15.99 | 54.11 | 46.44 | 44.68 | 72.06 | 50.74 | 73.32 | 31.83 | 122.57 | 150.81 | 148.03 | 135.78 | 527.49 | 525.52 | 524.53 | 942.29 | 0 |
Last Close Price | 0.68 | 0.67 | 0.66 | 0.78 | 1.42 | 1.30 | 1.43 | 3.25 | 2.36 | 3.92 | 1.81 | 7.02 | 10.24 | 10.05 | 10.02 | 9.82 | 9.80 | 9.77 | 9.74 | 9.71 |
Price Ratios
Fiscal Quarter | Current | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | - | - | - | - | - | - | - | - | - | 108.77 | - | - | - | 10.47 | - | - | - | - |
PS Ratio | 223.68 | 218.52 | 79.37 | 88.80 | 137.66 | 130.78 | 135.54 | 218.98 | 145.35 | 245.50 | 112.30 | 569.46 | 475.48 | - | 427.97 | - | - | - | - | - |
PB Ratio | 4.96 | 5.03 | -1.57 | -2.41 | -1.02 | -1.14 | -1.62 | -3.29 | -3.54 | -9.84 | -19.98 | 28.68 | -4.99 | -5.29 | -2.80 | -5.73 | -2.31 | -4.08 | -14.09 | - |
P/TBV Ratio | 2.36 | 2.30 | - | - | - | - | - | - | - | - | - | 30.91 | - | - | - | - | - | - | - | - |
EV Ratios
Fiscal Quarter | Current | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | 119.57 | 116.08 | 69.29 | 76.87 | 243.72 | 219.06 | 198.56 | 259.21 | 168.01 | 246.88 | 100.73 | 508.61 | 691.78 | - | 572.91 | - | - | - | - | - |
Financial Efficiency
Fiscal Quarter | Current | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | 0.07 | 0.07 | -0.06 | -0.10 | -0.96 | -0.99 | -1.04 | -0.83 | -0.68 | -0.70 | -0.23 | 0.42 | 0.11 | 0.09 | -0.94 | 0.00 | 0.00 | 0.00 | 0 | 0 |
Net Debt / Equity Ratio | -2.40 | -2.40 | 0.23 | 0.34 | -0.79 | -0.77 | -0.75 | -0.60 | -0.55 | -0.05 | 2.06 | -3.06 | -0.12 | -0.11 | -0.95 | -0.07 | -0.02 | -0.03 | 0.00 | 0.03 |
Net Debt / EBITDA Ratio | 1.07 | 1.07 | 0.13 | 0.13 | -1.21 | -0.97 | -0.74 | -0.53 | -0.35 | -0.02 | 0.20 | 1.02 | -0.20 | - | -3.98 | - | - | - | - | - |
Net Debt / FCF Ratio | 1.18 | 1.18 | 0.15 | 0.15 | -1.42 | -1.07 | -0.73 | -0.42 | -0.31 | -0.02 | 0.21 | 1.73 | -0.25 | -0.33 | -3.81 | -0.44 | -0.37 | -0.22 | 0.05 | - |
Asset Turnover | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | 0.04 | 0.06 | 0.02 | 0.01 | 0 | 0.00 | 0 | 0 | 0 | 0 | 0 |
Inventory Turnover | 0.63 | 0.63 | 0.54 | 0.49 | 0.49 | 0.48 | 0.48 | 0.54 | 0.55 | 0.52 | 0.58 | 0.50 | 0.92 | 0 | 0.77 | - | - | - | - | - |
Quick Ratio | 2.07 | 2.07 | 0.33 | 0.40 | 0.67 | 0.71 | 0.84 | 0.51 | 0.24 | 0.74 | 0.61 | 1.41 | 0.01 | 0.01 | 0.09 | 0.05 | 0.09 | 0.03 | 0.06 | 0.37 |
Current Ratio | 2.27 | 2.27 | 0.54 | 0.64 | 0.94 | 1.09 | 1.18 | 0.79 | 0.62 | 1.10 | 1.02 | 1.60 | 0.04 | 0.05 | 0.65 | 0.10 | 0.18 | 0.18 | 0.32 | 0.69 |
Return on Equity (ROE) | 3803.95% | 3803.95% | 155.22% | 165.23% | 87.33% | 90.67% | 201.72% | 207.55% | 191.33% | 497.29% | 157.60% | 231.86% | 634.63% | 408.48% | -9.04% | 2.38% | 4.26% | 3.47% | -0.06% | 0.00% |
Return on Assets (ROA) | -120.49% | -120.49% | -221.64% | -207.25% | -183.77% | -177.71% | -194.42% | -242.60% | -264.45% | -232.49% | -339.13% | -122.35% | -54.43% | 0.00% | -4.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Invested Capital (ROIC) | - | - | - | -3739.07% | -840.00% | -573.78% | -890.86% | - | -24348.47% | -1576.68% | - | -176.46% | -48.48% | 0.00% | -4.21% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Capital Employed (ROCE) | -316.59% | -316.59% | -4471.89% | -1279.92% | -667.73% | -573.78% | -772.40% | -3274.41% | 11847.20% | -1576.68% | -3589.25% | -339.69% | -72.50% | 0.00% | -4.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Yields
Fiscal Quarter | Current | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Earnings Yield | - | - | - | - | - | - | - | - | - | - | - | 0.92% | - | - | - | 9.55% | - | - | - | - |
Buyback Yield / Dilution | -80.58% | -80.57% | -23.78% | -11.08% | -18.40% | -30.56% | -52.83% | 10.38% | 31.01% | -47.34% | -21.46% | -108.16% | -143.91% | 0.01% | 0.04% | - | - | - | - | - |
Total Shareholder Return | -80.58% | -80.57% | -23.78% | -11.08% | -18.40% | -30.56% | -52.83% | 10.38% | 31.01% | -47.34% | -21.46% | -108.16% | -143.91% | 0.01% | 0.04% | - | - | - | - | - |